A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Global Deep Vein Thrombosis Market “. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2021 to 2030.
Global Deep Vein Thrombosis Market Analysis
According to cognizance market research the global deep vein thrombosis market was valued at USD 1,203.4 Million in 2020 and expected to register a CAGR of 5.7% from 2021 to 2030.
What is Global Deep Vein Thrombosis Market?
Deep vein thrombosis is the formation of a blood clot (also known as thrombus/thrombi) in the large veins of the body. This is common in lower legs but also can occur in other body parts. This blockage of the veins leads to swelling, pain, and redness of the affected area. It is warm to touch. This also occurs if the person has blood clotting problems especially after surgery or an accident. Being bed prone for a long time can also cause these clots. The most serious and dangerous side effect of Deep Vein Thrombosis is Pulmonary Embolism. It occurs in one-third of Deep Vein Thrombosis patients. In this part of clot/ full clot breaks free and travels through the blood vessels to the heart and then to the lungs. Here it can block the pulmonary artery or any of its branches. This causes shortness of breath, rapid heartbeat, chest pain. It can also lead to sudden death. Global Deep Vein Thrombosis Market is on the rise due to sedentary lifestyle in recent times.
Global Deep Vein Thrombosis Market Outlook
In the global deep vein thrombosis market report, the market outlook segment mainly includes important dynamics of the market which include drivers, restraints, opportunities and challenges tackled by the industry. Opportunities and challenges are extrinsic factors whereas, drivers and restraints are intrinsic factors of the market.
Many driving factors are the causes of the uprise in this market. Changing lifestyles of the people especially the emergence of a sedentary lifestyle is one of the major causes of the growth of this market. Due to increased industrial development, technological development, etc people are leading a very lazy lifestyle as manual work has drastically reduced. According to CDC, 1-2 people out of 1000 are affected by Deep Vein Thrombosis in the US. This immobile lifestyle causes obesity and further leads to the development of deep vein thrombosis. The Covid-19 pandemic is one of the recent causes for the market growth as obesity rates rapidly increased due to stay at home situation for more than a year. The large geriatric population also propels the market of Deep Vein Thrombosis. Deep Vein Thrombosis mainly affects people above 60 years. So aging population helps in the market growth. Increase in the government funding to develop novel treatments for such disorders boosts the market growth of Deep Vein Thrombosis. Extensive use of anticoagulants and heparin to treat complications by Deep Vein Thrombosis also helps the market rise. An increase digitalization has led to people being aware of these conditions and making conscious efforts to treat, control, cure it. This caused a boost in the market.
Along with these driving factors, many restraining factors may hamper market growth. Lack of knowledge regarding this condition especially in developing countries is one of the reasons. Lack of patient education and experienced professionals hamper the market growth. Side effects of anti-thrombosis drugs also hinder market growth as people become sceptical to administer them.
The global deep vein thrombosis market has been segmented into distribution channel, treatment and geography. Based on distribution channel the global deep vein thrombosis market is further segmented into hospital pharmacy, retail pharmacy and online pharmacy. Based on the treatment it is further segmented into inferior vena cava filters, blood thinners, compression stockings and clot busters.
Based on geography the global deep vein thrombosis market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. The North American region accounted for the largest share in the market in 2020 and expected to be remain dominant over the estimated time frame. North America region accounts for largest share as the demand for advanced treatments is high in this region. The people are well aware of this disorder and it severe side effects which leads to high treatment rate and helps the market. The high rate of drug approvals also is the cause of large market. Asia Pacific market is expected to grow due to increased government funding and expenditure on the healthcare. The increasing awareness among people is expected to boost the market.
The report offers the revenue of the global deep vein thrombosis market for the period 2019-2030, considering 2019 as a historical year, 2020 as the base year and 2021 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Global Deep Vein Thrombosis Market for the forecast period. The global deep vein thrombosis market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global deep vein thrombosis Market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the Global Deep Vein Thrombosis Market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the Global Deep Vein Thrombosis Market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the Global Deep Vein Thrombosis Market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the global deep vein thrombosis market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the Global Deep Vein Thrombosis Market. The subsequent section of the Global Deep Vein Thrombosis Market report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Global Deep Vein Thrombosis Market Competitive Landscape
The “Global Deep Vein Thrombosis Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Johnson and Johnson Services, Inc, Sanofi, Abbott Laboratories, Merck and Co, Daiichi Sankyo Company, GSK, Glenmark Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, Novartis AG, Bausch Health, Bristol-Myers Squibb Company, Pfizer among others.
The report explores the competitive scenario of the Global Deep Vein Thrombosis Market. Major players operating in the Global Deep Vein Thrombosis Market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the Global Deep Vein Thrombosis Market report.
Key Questions Answered in Global Deep Vein Thrombosis Market Report
- What are the major players operating in the global deep vein thrombosis market?
- What are trends, drivers, opportunities, and challenges in the global deep vein thrombosis market?
- Which is the leading country in the global deep vein thrombosis market?
- What are the revenue share forecasts of key sections of the global deep vein thrombosis market during the estimated timeframe?
- Which segment is expected to lead the global deep vein thrombosis market in terms of revenue by 2030?
- How partnerships & alliances among companies operating in the market are broadening the scope of the global deep vein thrombosis market?
- Who are the top 5 leaders of global deep vein thrombosis market?
- Which unmet needs will remain unaddressed over the projected period?
Global Deep Vein Thrombosis Market, by Distribution channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Deep Vein Thrombosis Market, by Treatment
- Inferior vena cava filters
- blood thinners
- compression stockings
- clot busters
Global Deep Vein Thrombosis Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa